Dueling court orders on the abortion drug mifepristone are threatening access to abortion and shaking up the US drug regulatory system. Legal challenges and appeals are underway in a battle that could affect millions of women.
The Justice Department on Monday appealed a Texas court ruling that invalidated the approval of the most commonly used abortion drug in the U.S., calling the decision extraordinary and unprecedented.